WallStreetZenWallStreetZen

Sectors & IndustriesHealthcareDiagnostics & Research
Best Diagnostic & Research Stocks to Buy Now (2022)
Top diagnostic & research stocks in 2022 ranked by overall Zen Score. See the best diagnostic & research stocks to buy now, according to analyst forecasts for the diagnostics & research industry.

Industry: Diagnostics & Research
Ticker
Company
Country
Market Cap
Shares
Institutional %
Insider %
Net Insider (L12M)
Net Insider (L3M)
SHC
SOTERA HEALTH CO
United States
$2.04B282,902,36757.47%42.53%Net Selling
MEDP
MEDPACE HOLDINGS INC
United States
$4.58B30,998,63627.45%72.55%Net BuyingNet Buying
SYNH
SYNEOS HEALTH INC
United States
$4.89B102,653,01733.12%66.88%Net SellingNet Selling
CODX
CO-DIAGNOSTICS INC
United States
$98.30M33,780,99221.60%23.02%Net Selling
QDEL
QUIDELORTHO CORP
United States
$4.83B66,952,94272.15%27.85%Net SellingNet Selling
NEOG
NEOGEN CORP
United States
$1.57B107,837,73097.07%2.93%Net BuyingNet Buying
FLGT
FULGENT GENETICS INC
United States
$1.15B30,265,75440.19%59.81%Net SellingNet Selling
LNTH
LANTHEUS HOLDINGS INC
United States
$4.58B68,741,88652.99%47.01%Net SellingNet Selling
DMTK
DERMTECH INC
United States
$121.66M30,039,94643.04%56.96%Net BuyingNet Selling
BWAY
BRAINSWAY LTD
Israel
$58.25M32,911,13421.51%0.00%
DRIO
DARIOHEALTH CORP
Israel
$93.75M22,979,12940.04%59.96%Net Selling
PHG
KONINKLIJKE PHILIPS NV
Netherlands
$13.51B870,182,44514.45%0.00%
QGEN
QIAGEN NV
Netherlands
$9.33B227,694,00055.06%0.00%
A
AGILENT TECHNOLOGIES INC
United States
$36.21B296,040,57085.65%1.10%Net BuyingNet Selling
DXCM
DEXCOM INC
United States
$31.54B392,581,77692.37%4.09%Net BuyingNet Buying
DGX
QUEST DIAGNOSTICS INC
United States
$14.37B116,606,29487.77%1.52%Net BuyingNet Buying
CSTL
CASTLE BIOSCIENCES INC
United States
$625.08M26,296,96883.09%16.91%Net SellingNet Selling
TMO
THERMO FISHER SCIENTIFIC INC
United States
$201.50B391,788,96285.46%0.86%Net SellingNet Selling
SERA
SERA PROGNOSTICS INC
United States
$52.08M31,002,20527.92%16.76%Net BuyingNet Selling
LHDX
LUCIRA HEALTH INC
United States
$48.53M40,106,49556.53%42.45%Net SellingNet Selling
ICLR
ICON PLC
Ireland
$14.98B81,526,60791.06%0.00%
SENS
SENSEONICS HOLDINGS INC
United States
$619.04M465,447,25824.11%41.02%Net SellingNet Selling
WAT
WATERS CORP
United States
$16.39B59,875,91988.00%8.00%Net BuyingNet Selling
CDNA
CAREDX INC
United States
$867.09M53,458,12681.91%18.09%Net SellingNet Selling
CRL
CHARLES RIVER LABORATORIES INTERNATIONAL INC
United States
$9.42B50,863,30794.76%3.24%Net SellingNet Selling
VIVO
MERIDIAN BIOSCIENCE INC
United States
$1.39B43,747,66988.58%11.42%Net Selling
OLK
OLINK HOLDING AB (PUBL)
Sweden
$1.51B119,007,06230.95%0.00%
MTD
METTLER TOLEDO INTERNATIONAL INC
United States
$25.16B22,506,61091.83%4.29%Net SellingNet Selling
IDXX
IDEXX LABORATORIES INC
United States
$27.58B83,253,70587.63%1.68%Net BuyingNet Selling
TWST
TWIST BIOSCIENCE CORP
United States
$1.91B56,363,51887.91%12.09%Net SellingNet Selling
BNGO
BIONANO GENOMICS INC
United States
$522.25M290,139,94028.35%9.03%Net BuyingNet Buying
NRC
NATIONAL RESEARCH CORP
United States
$978.80M24,767,11845.65%49.79%Net SellingNet Selling
MOTS
MOTUS GI HOLDINGS INC
United States
$7.13M2,996,83716.84%83.16%Net Buying
GENE
GENETIC TECHNOLOGIES LTD
Australia
$23.64M9,233,965,1430.00%0.00%
MXCT
MAXCYTE INC
United States
$585.42M101,724,40666.24%11.91%Net SellingNet Selling
AWH
ASPIRA WOMEN's HEALTH INC
United States
$43.23M112,296,38810.63%72.74%Net Buying
BNR
BURNING ROCK BIOTECH LTD
China
$274.33M105,108,84923.30%0.00%
PSNL
PERSONALIS INC
United States
$137.76M45,918,38961.90%19.89%Net SellingNet Selling
PKI
PERKINELMER INC
United States
$15.22B126,223,94486.03%2.42%Net SellingNet Selling
PRPO
PRECIPIO INC
United States
$18.83M22,736,4948.23%91.77%Net Buying
MYGN
MYRIAD GENETICS INC
United States
$1.48B80,634,76692.45%7.55%Net SellingNet Selling
CHEK
CHECK-CAP LTD
Israel
$33.53M116,411,9491.11%0.00%
BMRA
BIOMERICA INC
United States
$48.21M13,391,90118.11%42.41%
LH
LABORATORY CORP OF AMERICA HOLDINGS
United States
$19.02B90,400,00090.19%1.29%Net SellingNet Selling
NTRA
NATERA INC
United States
$4.13B96,957,36075.59%24.41%Net BuyingNet Selling
RNLX
RENALYTIX PLC
United Kingdom
$47.29M72,308,9307.86%0.00%
BVS
BIOVENTUS INC
United States
$539.06M77,450,89537.66%62.34%Net Selling
CNTG
CENTOGENE NV
Germany
$34.94M27,081,55711.65%0.00%
STIM
NEURONETICS INC
United States
$63.77M27,022,79652.92%47.08%Net BuyingNet Selling
CO
GLOBAL CORD BLOOD CORP
Hong Kong
$363.19M121,551,0759.64%59.71%
BIOC
BIOCEPT INC
United States
$13.54M16,922,86811.21%30.18%Net Selling
XGN
EXAGEN INC
United States
$50.41M16,260,44550.74%49.26%Net Selling
OPGN
OPGEN INC
United States
$19.04M48,326,9427.15%42.56%Net Buying
PACB
PACIFIC BIOSCIENCES OF CALIFORNIA INC
United States
$1.14B224,840,79993.26%6.74%Net SellingNet Selling
IQV
IQVIA HOLDINGS INC
United States
$34.71B186,507,93053.64%46.36%Net SellingNet Selling
ME
23ANDME HOLDING CO
United States
$1.35B451,524,89721.52%1.89%Net BuyingNet Buying
DHR
DANAHER CORP
United States
$191.07B727,445,35576.70%20.75%Net SellingNet Buying
ONVO
ORGANOVO HOLDINGS INC
United States
$17.69M8,711,95310.05%89.95%Net Selling
ISPC
ISPECIMEN INC
United States
$16.96M8,880,5984.20%62.41%Net Buying
GTH
GENETRON HOLDINGS LTD
China
$77.30M462,868,8043.79%0.00%
CEMI
CHEMBIO DIAGNOSTICS INC
United States
$10.82M30,224,6067.95%12.06%
CELC
CELCUITY INC
United States
$133.43M14,941,33431.29%29.53%Net BuyingNet Buying
ANIX
ANIXA BIOSCIENCES INC
United States
$151.16M30,661,69210.66%87.63%Net BuyingNet Buying
BDSX
BIODESIX INC
United States
$50.38M39,982,0489.31%58.68%Net BuyingNet Selling
AKU
AKUMIN INC
Canada
$161.13M89,516,51325.10%14.55%Net BuyingNet Buying
SLNO
SOLENO THERAPEUTICS INC
United States
$35.85M20,253,17726.41%73.59%Net Buying
EXAS
EXACT SCIENCES CORP
United States
$5.72B176,959,54390.77%3.33%Net BuyingNet Selling
GH
GUARDANT HEALTH INC
United States
$4.91B102,220,38959.66%40.34%Net BuyingNet Selling
MYNZ
MAINZ BIOMED NV
Germany
$101.96M14,482,9740.12%0.00%
ILMN
ILLUMINA INC
United States
$28.96B157,300,00085.59%1.81%Net SellingNet Selling
SQL
SEQLL INC
United States
$8.91M11,886,3790.07%23.75%Net BuyingNet Buying
NEO
NEOGENOMICS INC
United States
$1.12B125,795,90470.93%29.07%Net Selling
NDRA
ENDRA LIFE SCIENCES INC
United States
$19.58M63,174,4556.90%2.46%Net BuyingNet Buying
AXDX
ACCELERATE DIAGNOSTICS INC
United States
$131.31M81,559,92817.24%82.76%Net BuyingNet Buying
SRDX
SURMODICS INC
United States
$405.86M14,005,00062.51%37.49%Net SellingNet Buying
RDNT
RADNET INC
United States
$1.05B57,310,00057.85%42.15%Net Selling
VNRX
VOLITIONRX LTD
United States
$86.23M57,296,97310.40%51.83%Net BuyingNet Buying
NOTV
INOTIV INC
United States
$446.09M25,593,31352.00%45.29%Net BuyingNet Buying
LMDX
LUMIRADX LTD
United Kingdom
$269.97M254,686,9671.97%0.00%
HSKA
HESKA CORP
United States
$819.86M10,818,89551.61%48.39%Net BuyingNet Buying
HTGM
HTG MOLECULAR DIAGNOSTICS INC
United States
$6.74M11,048,1115.48%67.04%Net BuyingNet Selling
LAB
STANDARD BIOTOOLS INC
United States
$93.60M78,654,80255.79%38.52%Net BuyingNet Buying
PMD
PSYCHEMEDICS CORP
United States
$34.71M5,626,19626.67%50.53%Net Buying
OPK
OPKO HEALTH INC
United States
$1.40B771,959,57921.36%78.64%Net BuyingNet Buying
NVTA
INVITAE CORP
United States
$566.99M235,266,07788.07%5.05%Net SellingNet Selling
QTNT
QUOTIENT LTD
Jersey
$20.78M135,802,20150.06%49.94%Net BuyingNet Buying
TTOO
T2 BIOSYSTEMS INC
United States
$34.55M352,542,7285.38%11.23%Net Selling
PRE
PRENETICS GLOBAL LTD
Hong Kong
$399.53M110,979,3475.33%0.00%
ENZ
ENZO BIOCHEM INC
United States
$103.77M48,720,45443.29%38.33%Net BuyingNet Buying
TRIB
TRINITY BIOTECH PLC
Ireland
$22.78M83,606,8108.72%0.00%
MDXH
MDXHEALTH SA
Belgium
$95.14M155,969,2261.32%16.89%
VRAX
VIRAX BIOLABS GROUP LTD
United Kingdom
$34.58M11,374,0980.00%0.00%
BIAF
BIOAFFINITY TECHNOLOGIES INC
United States
N/A4,192,9190.00%0.00%

Diagnostic & Research Stocks FAQ

What are the best diagnostic & research stocks to buy right now in Sep 2022?

According to Zen Score, the 3 best diagnostic & research stocks to buy right now are:

1. Sotera Health Co (NASDAQ:SHC)


Sotera Health Co (NASDAQ:SHC) is the top diagnostic & research stock with a Zen Score of 61, which is 27 points higher than the diagnostic & research industry average of 34. It passed 20 out of 33 due diligence checks and has strong fundamentals. Sotera Health Co has seen its stock lose -72.5% over the past year, underperforming other diagnostic & research stocks by -34 percentage points.

Sotera Health Co has an average 1 year price target of $19.33, an upside of 168.14% from Sotera Health Co's current stock price of $7.21.

Sotera Health Co stock has a consensus Hold recommendation according to Wall Street analysts. Of the 7 analysts covering Sotera Health Co, 0% have issued a Strong Buy rating, 14.29% have issued a Buy, 71.43% have issued a hold, while 0% have issued a Sell rating, and 14.29% have issued a Strong Sell.

2. Medpace Holdings (NASDAQ:MEDP)


Medpace Holdings (NASDAQ:MEDP) is the second best diagnostic & research stock with a Zen Score of 59, which is 25 points higher than the diagnostic & research industry average of 34. It passed 20 out of 33 due diligence checks and has strong fundamentals. Medpace Holdings has seen its stock lose -22.68% over the past year, overperforming other diagnostic & research stocks by 16 percentage points.

Medpace Holdings has an average 1 year price target of $142.00, a downside of -3.87% from Medpace Holdings's current stock price of $147.71.

Medpace Holdings stock has a consensus Sell recommendation according to Wall Street analysts. Of the 2 analysts covering Medpace Holdings, 0% have issued a Strong Buy rating, 0% have issued a Buy, 50% have issued a hold, while 0% have issued a Sell rating, and 50% have issued a Strong Sell.

3. Syneos Health (NASDAQ:SYNH)


Syneos Health (NASDAQ:SYNH) is the third best diagnostic & research stock with a Zen Score of 57, which is 23 points higher than the diagnostic & research industry average of 34. It passed 18 out of 33 due diligence checks and has strong fundamentals. Syneos Health has seen its stock lose -49.59% over the past year, underperforming other diagnostic & research stocks by -11 percentage points.

Syneos Health has an average 1 year price target of $88.14, an upside of 85.1% from Syneos Health's current stock price of $47.62.

Syneos Health stock has a consensus Buy recommendation according to Wall Street analysts. Of the 9 analysts covering Syneos Health, 44.44% have issued a Strong Buy rating, 11.11% have issued a Buy, 44.44% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the diagnostic & research stocks with highest dividends?

Out of 9 diagnostic & research stocks that have issued dividends in the past year, the 3 diagnostic & research stocks with the highest dividend yields are:

1. Koninklijke Philips Nv (NYSE:PHG)


Koninklijke Philips Nv (NYSE:PHG) has an annual dividend yield of 6.21%, which is 5 percentage points higher than the diagnostic & research industry average of 1.71%. Koninklijke Philips Nv's dividend payout is not stable, having dropped more than 10% three times in the last 10 years. Koninklijke Philips Nv's dividend has not shown consistent growth over the last 10 years.

Koninklijke Philips Nv's dividend payout ratio of 24.8% indicates that its high dividend yield is sustainable for the long-term.

2. Psychemedics (NASDAQ:PMD)


Psychemedics (NASDAQ:PMD) has an annual dividend yield of 3.08%, which is 1 percentage points higher than the diagnostic & research industry average of 1.71%. Psychemedics's dividend payout is not stable, having dropped more than 10% one times in the last 10 years. Psychemedics's dividend has not shown consistent growth over the last 10 years.

Psychemedics's dividend payout ratio of -57.1% indicates that its dividend yield might not be sustainable for the long-term.

3. Quest Diagnostics (NYSE:DGX)


Quest Diagnostics (NYSE:DGX) has an annual dividend yield of 2.08%, which is the same as the diagnostic & research industry average of 1.71%. Quest Diagnostics's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Quest Diagnostics's dividend has shown consistent growth over the last 10 years.

Quest Diagnostics's dividend payout ratio of 20.8% indicates that its dividend yield is sustainable for the long-term.

Why are diagnostic & research stocks down?

Diagnostic & research stocks were down -1.17% in the last day, and down -6.9% over the last week.

We couldn't find a catalyst for why diagnostic & research stocks are down.

What are the most undervalued diagnostic & research stocks?

Based on WallStreetZen's Valuation Score, the 3 most undervalued diagnostic & research stocks right now are:

1. Syneos Health (NASDAQ:SYNH)


Syneos Health (NASDAQ:SYNH) is the most undervalued diagnostic & research stock based on WallStreetZen's Valuation Score. Syneos Health has a valuation score of 86, which is 49 points higher than the diagnostic & research industry average of 37. It passed 6 out of 7 valuation due diligence checks.

Syneos Health's stock has dropped -49.59% in the past year. It has underperformed other stocks in the diagnostic & research industry by -11 percentage points.

2. Sotera Health Co (NASDAQ:SHC)


Sotera Health Co (NASDAQ:SHC) is the second most undervalued diagnostic & research stock based on WallStreetZen's Valuation Score. Sotera Health Co has a valuation score of 86, which is 49 points higher than the diagnostic & research industry average of 37. It passed 6 out of 7 valuation due diligence checks.

Sotera Health Co's stock has dropped -72.5% in the past year. It has underperformed other stocks in the diagnostic & research industry by -34 percentage points.

3. Quidelortho (NASDAQ:QDEL)


Quidelortho (NASDAQ:QDEL) is the third most undervalued diagnostic & research stock based on WallStreetZen's Valuation Score. Quidelortho has a valuation score of 86, which is 49 points higher than the diagnostic & research industry average of 37. It passed 6 out of 7 valuation due diligence checks.

Quidelortho's stock has dropped -49.01% in the past year. It has underperformed other stocks in the diagnostic & research industry by -10 percentage points.

Are diagnostic & research stocks a good buy now?

45.24% of diagnostic & research stocks rated by analysts are a strong buy right now. On average, analysts expect diagnostic & research stocks to rise by 49.82% over the next year.

What is the average p/e ratio of the diagnostics & research industry?

The average P/E ratio of the diagnostics & research industry is -57.71x.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.